Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ST. JOHN'S, Newfoundland and Labrador, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF) ("Kraken" or the "Company"), is pleased to announce that it has changed...
-
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- (Via ESG News) ESG News releases Marisa Drew Chief Sustainability Officer, Standard Chartered one-on-one interview with Force for Good Host and Chairman...
-
NEWTOWN SQUARE, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) -- ArriVent Biopharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical...
-
Hepalys Pharma, Inc. est une nouvelle société créée par Catalys Pacific, et dans laquelle Inventiva détient une participation de 30%. Dans le cadre de l’accord de licence exclusif, Inventiva...
-
Hepalys Pharma, Inc. is a new company created by Catalys Pacific and in which Inventiva has a 30% ownership position. Under the exclusive licensing agreement, Inventiva will receive a $10 million...
-
OTTAWA, 20 sept. 2023 (GLOBE NEWSWIRE) -- Selon une nouvelle étude réalisée pour le compte du Conseil canadien de l’industrie des dépanneurs (CCID), le marché du tabac de contrebande au Canada est...
-
OTTAWA, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The contraband tobacco market in Canada is a growing pan-Canadian problem fueled by organized crime and cheating governments and Canadians out of billions...
-
TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- York University’s Schulich School of Business and Techstars Toronto have formalized a new annual talent partnership, with six top Schulich MBAs assigned...
-
NEW YORK, NY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Interested in solving some of the biggest challenges facing humanity? Starting today, young people aged 11 to 24 can compete for cash prizes in the...
-
WATERTOWN, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of...